Publications by authors named "P Poignard"

Claim this Profile
E
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trial.
Clément R Massonnaud, Nathan Peiffer-Smadja, Pascal Poignard, Simon Jamard, François Goehringer

Clin Microbiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques.
Hélène Letscher, Delphine Guilligay, Gregory Effantin, Axelle Amen, Guidenn Sulbaran, Pascal Poignard

NPJ Vaccines· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Existing Anti-Vector Immunity to Adenovirus-Inspired VLP Vaccines Shows an Adjuvant-Dependent Antagonism.
Salomé Gallet, Dalil Hannani, Sebastian Dergan-Dylon, Emilie Vassal-Stermann, Isabelle Bally, Pascal Poignard

Vaccines (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants.
Léa Dépéry, Isabelle Bally, Axelle Amen, Benjamin Némoz, Marlyse Buisson, Pascal Poignard

Microbiol Spectr· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target-agnostic identification of human antibodies to sexual forms reveals cross-stage recognition of glutamate-rich repeats.
Axelle Amen, Randy Yoo, Amanda Fabra-García, Judith Bolscher, William J R Stone, Pascal Poignard

Elife· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis